Although pharmacological administration of leptin dramatically decreases food intake and increases energy expenditure in the rare patients with leptin deficiency, leptin itself has limited potential as an obesity therapeutic. The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.